arrow
Back
H

Han Chu Lee

University of Ulsan College of Medicine

64H-index
408Paper Count
1.6WCitation Count
Published Papers 169
Publication Date
Identification of Prognostic Factors and Regulatory Pathways in Porto-Sinusoidal Vascular Disorder
err2026-10-01
err0
errOAAI
errSubin Heo; Do Kyung Yoon; Soyeon Shin; Dami Youn; Youngeun Yoo; In Hye Song; Hyo Jeong Kang; Young-In Yoon; Kyunggon Kim; Seung Soo Lee; Sung Won Chung; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Mark Muthiah; Ho-Su Lee; Won-Mook Choi
errShare
errSave
Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma
err2026-06-11
err0
errOAAI
errAnne Victoire Odent; Claudia Campani; Mohamed Bouattour; Yann Touchefeu; Victoria Delhoume; Olivier Rosmorduc; Alina Pascale; Jihyun An; Han Chu Lee; Hélène Regnault; Dominique Thabut; Giuliana Amaddeo; Massih Ningararhi; Isabelle Olivier-Hourmand; Chloe Metivier; Maxime Ronot; Line Ntandja-Wandji; Violaine Ozenne; Sabrina Sidali; Fabio Marra
errShare
errSave
Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
err2026-04-24
err0
errOAAI
errPark, Hyo Jung; Lee, Dong Ho; Chang, Won; Kim, Hae Young; Kim, Dong Hwan; Choi, Won-Mook; Chung, Sung Won; Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Lee, Han Chu; Lim, Young-Suk; Kim, Seon-Ok; Singal, Amit G.; Kim, So Yeon
errShare
errSave
Updated data from IMbrave050: Adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma
err2026-01-22
err0
PREAI
errAdam Yopp; Minshan Chen; Ann-Lii Cheng; Ahmed Kaseb; Masatoshi Kudo; Han Chu Lee; Edward Cha; Stephen Paul Hack; Qinshu Lian; Jessica Spahn; Chun Wu; Shukui Qin; Pierce Kah-Hoe Chow
errShare
errSave
Combined Transarterial Chemoembolization and External Beam Radiotherapy for Identifying Surgical Candidates for Hepatocellular Carcinoma with Macroscopic Vascular Invasion: A Propensity Score-Weighted Analysis
err2026-01-01
err1
errOAAI
errLee, Sumin; Jung, Jinhong; Choi, Jonggi; Kim, So Yeon; Kim, Jin Hyoung; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Song, Gi-Won; Park, Jin-hong; Yoon, Sang Min
errShare
errSave
Transarterial Chemoembolization Alone versus Combined with Radiotherapy as First-Line Therapy for Early-Stage Single Hepatocellular Carcinoma
err2025-12-09
err0
PREAI
errHye In Lee; Jinhong Jung; So Yeon Kim; Jonggi Choi; Danbi Lee; Ju Hyun Shim; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Sang Min Yoon
errShare
errSave
Abbreviated gadoxetic acid–enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol
err2025-12-01
err0
errOAAI
errPark, Hyo Jung; Choi, Jonggi; Kim, Dong Wook; Choi, Sang Hyun; Choi, Won-Mook; Chung, Sung Won; Lee, Danbi; Shim, Ju Hyun; Lee, Han Chu; Lim, Young-Suk; Kim, Min-Ju; Singal, Amit G.; Park, Seong Ho; Kim, So Yeon
errShare
errSave
The “A-B-C” classification reveals outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab
err2025-11-25
err0
errOAAI
errClaudia Campani; Clelia Galvanin; Ju Hyun Shim; Mohamed Bouattour; Yann Touchefeu; Victoria Delhoume; Olivier Rosmorduc; Alina Pascale; Jihyun An; Han Chu Lee; Helene Regnault; Dominique Thabut; Valérie Paradis; Julien Calderaro; Marianne Ziol; Aurélie Beaufrère; Alexandre Sayadi; Giuliana Amaddeo; Manon Allaire; Isabelle Olivier-Hourmand
errShare
errSave
Risk of Extrahepatic Malignancies in Patients With Autoimmune Hepatitis: A Nationwide Cohort Study
err2025-10-01
err0
PREAI
errChung, Sung Won; Kim, Ye-Jee; Lim, Jihye; Choi, Jonggi; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Kim, Sehee; Choi, Won-Mook
errShare
errSave
Association Between Viral Replication Activity and Postoperative Recurrence of HBV-Related Hepatocellular Carcinoma
err2025-03-16
err4
errOAAI
errHeo, S; Yang, J; Park, J; Hui, RWH; Song, BG; Song, IH; Yoon, YI; Cheung, TT; Chung, SW; Choi, J; Lee, D; Shim, JH; Kim, KM; Lim, YS; Lee, HC; Seto, WK; Lee, JH; Choi, WM
errShare
errSave
Risk of Variceal Bleeding in Patients Receiving Atezolizumab-Bevacizumab Treatment for Hepatocellular Carcinoma
err2025-01-28
err0
PREAI
errPark, Kanghee; Lee, Hye Won; Kim, Euichang; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Yoo, Changhoon; Ryoo, Baek-Yeol; Han, Seungbong; Choi, Jonggi
errShare
errSave
Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population
err2024-11-01
err0
PREAI
errChoi, Jonggi; Jo, Chanyoung; Kim, Sollip; Ryu, Mi; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu
errShare
errSave
Higher Risk of Proteinuria with Atezolizumab plus Bevacizumab than Lenvatinib in First-Line Systemic Treatment for Hepatocellular Carcinoma
err2024-10-16
err0
errOAAI
errYang, Jiwon; Choi, Won-Mook; Kim, Hyung-Don; Choi, Jonggi; Yoo, Changhoon; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu
errShare
errSave
Limited Generalizability of Retrospective Single-Center Cohort Study in Comparison to Multicenter Cohort Study on Prognosis of Hepatocellular Carcinoma
err2024-07-01
err0
errOAAI
errKim, Ye Rim; Chung, Sung Won; Kim, Min-Ju; Choi, Won-Mook; Choi, Jonggi; Lee, Danbi; Lee, Han Chu; Shim, Ju Hyun
errShare
errSave
errShare
errSave
Improving the hepatitis C virus care cascade with the in-hospital Reflex tEsting ALarm-C (REAL-C) model
err2024-02-20
err0
PREAI
errChoi, Jonggi; Park, Jina; Choi, Won-Mook; Lee, Danbi; Shim, Ju Hyun; Kim, Kang Mo; Lim, Young-Suk; Lee, Han Chu; Kwon, Sujin; Hwang, Sang-Hyun
errShare
errSave
Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
err2024-02-19
err14
errOAAI
errKim, Hyung-Don; Jung, Seyoung; Lim, Ho Yeong; Ryoo, Baek-Yeol; Ryu, Min-Hee; Chuah, Samuel; Chon, Hong Jae; Kang, Beodeul; Hong, Jung Yong; Lee, Han Chu; Moon, Deok-Bog; Kim, Ki-Hun; Kim, Tae Won; Tai, David; Chew, Valerie; Lee, Jeong Seok; Finn, Richard S.; Koh, June-Young; Yoo, Changhoon
errShare
errSave
Response to atezolizumab plus bevacizumab specific for lung and lymph node metastases affects survival of patients with HCC
err2024-01-30
err0
PREAI
errYang, Jiwon; Choi, Jonggi; Choi, Won-Mook; Kim, Kang Mo; Lee, Han Chu; Shim, Ju Hyun
errShare
errSave
A risk prediction model for hepatocellular carcinoma in non-alcoholic fatty liver disease without cirrhosis
err2023-12-18
err3
PREAI
errKim, Gi-Ae; Park, Yewan; Oh, Shin Ju; Jung, Jooyi; Han, Seungbong; Chang, Hye-Sook; Park, Sung Won; Kim, Tae Hyup; Park, Hye Won; Choe, Jaewon; Kim, Jaeil; Lee, Han Chu
errShare
errSave